Platform
Features
Pricing
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Bravado
6 followers
Invivyd
1 follower
Abeona Therapeutics
Annexon Biosciences
2 followers
Immunai
Goalbook
VentureWell
Rethink Ed
Thermo Fisher Scientific
155 followers
Agilent Technologies
63 followers
Myriad Genetics
35 followers
Explore companies